<unk> (64Cu) oxodotreotide or<unk> Cu 64 dotatate, sold under the brand name Detectnet, is a radioactive diagnostic agent indicated for use with positron emission tomography (PET) for localization of somatostatin receptor positive neuroendocrine tumors (NETs) in adults. Common side effects include nausea, vomiting and flushing. It was approved for medical use in the United States in September 2020.
Copper 
Iron
Biotin
Zinc
Sybil 
Lindane
Lead
Chorus